menu
    • menu
    [{"orgOrder":0,"company":"Sami-Sabinsa Group","sponsor":"Postbiotics","pharmaFlowCategory":"D","therapeuticArea":"Gastroenterology","country":"INDIA","productType":"Large molecule","year":"2024","type":"Agreement","leadProduct":"Lactobacillus Paracasei","moa":"","graph1":"Gastroenterology","graph2":"Approved","graph3":"Sami-Sabinsa Group","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"","sponsorNew":"Sami-Sabinsa Group \/ Postbiotics","highestDevelopmentStatusID":"12","companyTruncated":"Sami-Sabinsa Group \/ Postbiotics"}]

    Find Clinical Drug Pipeline Developments & Deals by Sami-Sabinsa Group

    Menu

    Sami-Sabinsa Group

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
    filter

    Year

    filter

    DEALS // DEV.

    filter

    Country

    filter
    Sponsor
    filter

    Therapeutic Area

    filter

    Study Phase

    filter

    Deal Type

    filter

    Product Type

    filter

    Dosage Form

    filter

    Lead Product

    filter

    Target

    refresh Filters
    refresh Reset Filter
    refresh Reset Filter
    price-trend All Developments

    Therapeutic Area by Lead Product

    ForexGraph

    Study Phase by Lead Product

    ForexGraph

    Company by Lead Product

    ForexGraph

    Top Deals by Deal Size (USD bn)

    ForexGraph

    01

    Sami-Sabinsa Group

    India arrow
    BePharma
    Not Confirmed

    Sami-Sabinsa Group

    India arrow
    BePharma
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Lactobacillus Paracasei

    Therapeutic Area : Gastroenterology

    Study Phase : Approved

    Sponsor : Postbiotics

    Deal Size : Undisclosed

    Deal Type : Agreement

    DEALS_DEV arrow-down

    Sabinsa And Postbiotics Ink Deal for PoZibio Dietary Supplement

    Details : The distribution agreement aims for the dietary supplement and functional food ingredient PoZibio for age-related digestive health conditions including Leaky Gut Syndrome (LGS).

    Product Name : PoZibio

    Product Type : Large molecule

    Upfront Cash : Undisclosed

    October 23, 2024

    Lead Product(s) : Lactobacillus Paracasei

    Therapeutic Area : Gastroenterology

    Highest Development Status : Approved

    Sponsor : Postbiotics

    Deal Size : Undisclosed

    Deal Type : Agreement

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth